AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

That bar was set by an experimental pill from Novo Nordisk that demonstrated 5% weight loss in four weeks, he noted. Hsieh also said Viking's pill showed a "highly benign tolerability profile ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable online pharmacies in search of weight loss drugs at ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...